Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Gains from Investment Securities: 2011-2025

Historic Gains from Investment Securities for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to -$1.6 million.

  • Mesa Laboratories' Gains from Investment Securities fell 35.67% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 14834.15%. This contributed to the annual value of $155,000 for FY2025, which is 20.10% down from last year.
  • Latest data reveals that Mesa Laboratories reported Gains from Investment Securities of -$1.6 million as of Q3 2025, which was down 30.24% from -$1.2 million recorded in Q2 2025.
  • Mesa Laboratories' Gains from Investment Securities' 5-year high stood at $11.4 million during Q4 2024, with a 5-year trough of -$14.5 million in Q1 2025.
  • For the 3-year period, Mesa Laboratories' Gains from Investment Securities averaged around $23,545, with its median value being -$1.1 million (2023).
  • In the last 5 years, Mesa Laboratories' Gains from Investment Securities skyrocketed by 10,600.00% in 2023 and then tumbled by 790.61% in 2025.
  • Mesa Laboratories' Gains from Investment Securities (Quarterly) stood at $595,000 in 2021, then crashed by 185.04% to -$506,000 in 2022, then spiked by 1,249.80% to $5.8 million in 2023, then surged by 95.58% to $11.4 million in 2024, then plummeted by 35.67% to -$1.6 million in 2025.
  • Its Gains from Investment Securities stands at -$1.6 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$14.5 million for Q1 2025.